11/29
07:16 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
11/26
01:40 pm
agio
Rating for AGIO
Low
Report
Rating for AGIO
11/26
01:40 pm
agio
Rating for AGIO
Low
Report
Rating for AGIO
11/26
06:04 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Low
Report
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
11/26
05:55 am
agio
Agios Pharmaceuticals initiated with a Buy at Citi (yesterday)
Low
Report
Agios Pharmaceuticals initiated with a Buy at Citi (yesterday)
11/21
02:17 pm
agio
Rating for AGIO
Medium
Report
Rating for AGIO
11/20
09:55 am
agio
Rating for AGIO
Low
Report
Rating for AGIO
11/20
09:55 am
agio
Rating for AGIO
Low
Report
Rating for AGIO
11/20
08:05 am
agio
Agios Pharmaceuticals (NASDAQ:AGIO) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $34.00 price target on the stock, down previously from $40.00.
Medium
Report
Agios Pharmaceuticals (NASDAQ:AGIO) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $34.00 price target on the stock, down previously from $40.00.
11/20
07:49 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
11/20
07:47 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
11/20
07:47 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
11/20
07:47 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
11/20
06:02 am
agio
Agios Pharmaceuticals upgraded to Outperform from Market Perform at Leerink
Medium
Report
Agios Pharmaceuticals upgraded to Outperform from Market Perform at Leerink
11/19
01:16 pm
agio
Agios Pharmaceuticals (NASDAQ:AGIO) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $28.00 price target on the stock.
Low
Report
Agios Pharmaceuticals (NASDAQ:AGIO) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $28.00 price target on the stock.
11/19
01:16 pm
agio
Agios Pharmaceuticals (NASDAQ:AGIO) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $28.00 price target on the stock.
Low
Report
Agios Pharmaceuticals (NASDAQ:AGIO) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $28.00 price target on the stock.
11/19
12:34 pm
agio
Agios downgraded to Sector Perform from Outperform at RBC Capital
Medium
Report
Agios downgraded to Sector Perform from Outperform at RBC Capital
11/19
12:34 pm
agio
Agios downgraded to Sector Perform from Outperform at RBC Capital
Medium
Report
Agios downgraded to Sector Perform from Outperform at RBC Capital